Literature DB >> 15856186

Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition.

Catherine C Tenn1, Shitij Kapur, Paul J Fletcher.   

Abstract

RATIONALE: Schizophrenia has been linked to dysregulation of dopamine and glutamate transmitter systems. Attempts to model aspects of schizophrenia in animals have made use of treatments that primarily affect dopaminergic (e.g., amphetamine, Amp) and glutamatergic (e.g., phencyclidine, PCP) function. In addition to exerting short-term acute effects, these agents also induce long-term effects, as seen, for example, in neurochemical and behavioural sensitization.
OBJECTIVES: The goal of this work was to compare Amp- and PCP-sensitized states on two measures of information processing that are impaired in schizophrenia, prepulse inhibition (PPI) of the acoustic startle reflex and latent inhibition (LI).
METHODS: Rats received injections of Amp, PCP or saline 3 days per week for 3 weeks. The Amp dose increased from 1 to 3 mg/kg, at the rate of 1 mg/kg each week. The PCP dose was 3 mg/kg throughout. After various periods of withdrawal rats were tested for PPI and LI.
RESULTS: Repeated intermittent treatment with Amp or PCP resulted in augmented locomotor responses to challenge with each drug, providing an operational index that sensitization had occurred. Rats sensitized to Amp showed disrupted PPI when tested drug free at 3, 21 and 60 days of withdrawal. Amp-sensitized rats also showed abolition of the LI effect. Rats sensitized to PCP did not show deficits in any of these behaviours when tested drug free.
CONCLUSIONS: Because disrupted PPI and LI have both been reported in schizophrenic patients, these results suggest that the Amp-sensitized state may represent a useful model for investigating the neural bases of information processing deficits in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856186     DOI: 10.1007/s00213-005-2253-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

Authors:  J D Jentsch; J D Elsworth; D E Redmond; R H Roth
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

2.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

3.  Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.

Authors:  Holger Russig; Carol A Murphy; Joram Feldon
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

4.  Gating and habituation of the startle reflex in schizophrenic patients.

Authors:  D L Braff; C Grillon; M A Geyer
Journal:  Arch Gen Psychiatry       Date:  1992-03

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 6.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

7.  Amphetamine response and relapse risk after depot neuroleptic discontinuation.

Authors:  B Angrist; E Peselow; M Rubinstein; A Wolkin; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.

Authors:  B D Greenberg; D S Segal
Journal:  Pharmacol Biochem Behav       Date:  1985-07       Impact factor: 3.533

9.  Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats.

Authors:  T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

Authors:  A C Lahti; H H Holcomb; D R Medoff; C A Tamminga
Journal:  Neuroreport       Date:  1995-04-19       Impact factor: 1.837

View more
  21 in total

1.  Extended access to methamphetamine self-administration affects sensorimotor gating in rats.

Authors:  Martin Hadamitzky; Athina Markou; Ronald Kuczenski
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

Review 2.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 3.  Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system.

Authors:  Cecilia Flores
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

Review 4.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex.

Authors:  Haosheng Sun; Paul J Cocker; Fiona D Zeeb; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2011-08-02       Impact factor: 4.530

6.  Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood.

Authors:  Andrew R Abela; Arya Rahbarnia; Suzanne Wood; Anh D Lê; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2019-01-29       Impact factor: 4.530

7.  Role of nitric oxide in amphetamine-induced sensitization of schedule-induced polydipsic rats.

Authors:  Yia-Ping Liu; Che-Se Tung; Pai-Jone Lin; Fang-Jung Wan
Journal:  Psychopharmacology (Berl)       Date:  2011-05-28       Impact factor: 4.530

8.  Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.

Authors:  Ming Li; Wei He; Alexa Mead
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

9.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Authors:  Alice Egerton; Lee Reid; Sandie McGregor; Susan M Cochran; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2008-04-23       Impact factor: 4.530

10.  Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task.

Authors:  Jessica J Stanis; Hector Marquez Avila; Martin D White; Joshua M Gulley
Journal:  Psychopharmacology (Berl)       Date:  2008-05-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.